Several studies have documented an increased expression of NLRP3 inflammasome components in renal parenchymal cells in experimental and human DKD and hence speculated on a role of IL-1β in CKD progression (18, 43–46). This evidence concerns the gene NLRP3 and diabetic kidney disease.